Lundbeck, Myriad Shares Fall on Alzheimer's Setback (Update1) - Bloomberg
Lundbeck, Myriad Shares Fall on Alzheimer's Setback (Update1) Bloomberg - Elan Corp. and partner Wyeth earlier this month said that while their experimental Alzheimer's treatment, called AAB-001 or bapineuzumab, failed to meet the ... |
Original post: Lundbeck, Myriad Shares Fall on Alzheimer's Setback (Update1) - Bloomberg by ©2008 Google at alzheimers treatment - Google News
Blog tag: Alzheimers treatment
Technorati tag: Alzheimers treatment